DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Boston Convention and Exhibition Center

2013年6月23日 (日) 午前 8:30 - 2013年6月27日 (木) 午後 12:45

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Legal Jeopardy from the Conduct of Clinical Trials

Session Chair(s)

Mark C. Hegarty, JD

Mark C. Hegarty, JD

Partner/Attorney

Shook, Hardy & Bacon L.L.P., United States

This forum will address a wide range of regulatory and legal issues governing modern clinical research. Using a well known game show format, experts will compete to show their knowledge of the elements of informed consent, IRB requirements, FDA regulations, the history of clinical investigations and other key topics. The audience will also participate in the game show format.

Learning Objective : Identify the civil and criminal liability risks of conducting clinical trials through case studies; Describe the sponsor's and CRO's exposure to regulatory liability for failure to properly monitor research; Identify what types of clinical trial misconduct could give rise to a criminal prosecution; Discuss recent trends as to liability.

Speaker(s)

John M. Isidor, JD

Panelist

John M. Isidor, JD

Human Subject Protection Consulting, LLC, United States

Chief Executive Officer

Jeffrey N. Gibbs, JD

Panelist

Jeffrey N. Gibbs, JD

Hyman Phelps & McNamara, PC, United States

Director

Kate Gallin Heffernan, FFPM

Contestant

Kate Gallin Heffernan, FFPM

Verrill Dana LLP, United States

Counsel

David  Forster, JD, MA

Contestant

David Forster, JD, MA

WCG, United States

Chief Compliance Officer

Marc B. Wilenzick, JD

Contestant

Marc B. Wilenzick, JD

ViS Research Institute, United States

Head, Stakeholder Engagement

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。